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Ovarian cancer is believed to develop from the ovarian surface epithelium through the accumulation of aberrations of oncogenes
and/or tumor suppressor genes. However, it is unclear how the gene abnormalities are involved in ovarian carcinogenesis. To
elucidate the process, we transfected genes reported to show their abnormalities in human ovarian cancers into human ovarian
surface epithelial cells. Immortalization of the cells was achieved by the transfection of SV40 large T antigen (LT) and human
telomerase reverse transcriptase (hTERT); however, the resultant cells showed no tumorigenesis. Additional transfection of either c-
erbB-2 or mutant Ha-ras into the immortalized cells showed the anchorage-independent growth and tumorigenesis in mice with the
incidence of 50% and 40%, respectively. Histologically, all the tumours were undifferentiated. In association with the tumorigenesis,
the cells expressing c-erbB-2 or mutant Ha-ras demonstrated increased vascular endothelial growth factor secretion under hypoxia
and enhanced resistance to apoptosis compared with the immortalized cells. Collectively, the introduction of either c-erbB-2 or
mutant Ha-ras in the cells, which were efficiently immortalized by the transfection of LT and hTERT, showed tumorigenicity,
suggesting that c-erbB-2 or mutant Ha-ras genes might be involved in ovarian carcinogenesis.
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Ovarian cancer is the leading cause of death in women with
gynaecological malignant tumours (Herbst, 1994). Despite the
recent developments in aggressive surgery and chemotherapy, the
prognosis remains poor because ovarian cancers are often not
diagnosed until advanced stages and the cancer cells frequently
acquire drug resistance during repeated chemotherapies. Thus,
there is an urgent need to develop new therapies. Epithelial
ovarian cancer is believed to develop from the ovarian surface
epithelium (OSE) (Scully, 1977), through the accumulation of
aberrations of oncogenes and/or tumour suppressor genes. Many
gene abnormalities have been detected in ovarian cancers, for
example, the overexpression of c-erbB-2, mutation of Ki-ras, p53,
BRCA1 or BRCA2, and the expression of telomerase activity
(Matias-Guiu and Prat, 1998). Nonetheless, it is still unclear how
the gene abnormalities are involved in the process of ovarian
carcinogenesis.
Human OSE cells provide a useful in vitro culture system for the
analysis of pathogenesis of ovarian cancers using molecular
biology and genetic techniques. Two studies on malignant
transformation of human OSE cells by gene transfection have
been reported (Ong et al, 2000; Nitta et al, 2001). A recent report
demonstrated that transfection of human telomerase reverse
transcriptase (hTERT) into SV40 large T antigen (LT)-transfected
human somatic cells showed 100% immortalization in transfected
cells (Hahn et al, 1999). Therefore, in the present study, we tried to
induce malignant transformation of cultured human OSE by
transfecting genes that were shown to be altered in human ovarian
cancers. We also tried to analyse the phenotypic change induced in
the transformation process.
MATERIALS AND METHODS
Cell culture
Human OSE cells were obtained with written consent from patients
who underwent abdominal surgery for benign gynaecological
diseases. Ovarian surface epithelium cells were collected during
surgery and cultured as previously reported (Kuroda et al, 2001).
The purity of the cultured OSE cells was confirmed by positive
immunostaining of both cytokeratin and vimentin with negative
staining of factor-VIII-related antigen (Auersperg et al, 1994). The
human ovarian cancer cell line A2780 was maintained as
previously reported (Tsuruta et al, 2001). The fibroblast cell line
NIH 3T3 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Nissui, Tokyo, Japan) with 10% FCS.
Gene transfection
Subconfluent cultures of OSE cells in passage 1 were transfected
with 20mg of pSV3neo, which contains LT gene, using the
Lipofectin reagent (Gibco, NY, USA). Next, we transfected 20mg
of hTERT plasmid (pcDNA3-hTERTn2) into LT-transfected OSE
cells. Cells expressing the hTERT gene were selected in media
supplemented with 400mgml
 1 of G418 and were cloned. We
finally transfected 20mg of the c-erbB-2 plasmid (pSV2erbB2)
or the mutant Ha-ras plasmid (pSNTT) into hTERT- and
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sLT-transfected OSE cells with 5mg pHygEGFP vector (Clontech,
CA, USA). We harvested those clones that fluoresced as success-
fully transfected cells.
Western blotting
Western blotting was performed as previously described (Tsuruta
et al, 2001). We used the following antibodies as a probe: anti-
SV40 mouse monoclonal antibody (Santa Cruz, CA, USA), anti-
Ha-ras mouse monoclonal antibody (Santa Cruz) and anti-c-erbB-2
rabbit polyclonal antibody (Nichirei, Tokyo, Japan).
RT–PCR analysis
The expression of hTERT mRNA and the telomerase activity were
performed by RT–PCR and by stretch PCR assay, respectively, as
previously reported (Kyo et al, 1999).
Immunohistochemistry
Tumour tissues were fixed in 10% buffered formalin, embedded in
paraffin and sectioned. Sections were stained with haematoxylin
and eosin. For the immunohistochemical staining, they were
deparaffinized in xylol for 30min and processed as previously
described (Kuroda et al, 2001). We used the following antibodies
as primary antibodies: a rabbit polyclonal anti-cytokeratin anti-
body (Santa Cruz), a rabbit polyclonal anti-vimentin antibody
(Santa Cruz), a mouse monoclonal anti-CA125 antibody (Dako,
CA, USA) or a mouse monoclonal anti-SV40 large T antigen (Santa
Cruz).
Life span determinations
Cells were seeded on 35mm collagen type-I-coated culture dishes.
When confluent, the cells were trypsinized and seeded at 1:3 split
ratio. This process was continued until the cells became stationary
(senescence), that is did not become confluent after 1 month in
culture. The population doublings (PDs) were added for each
passage until the stationary phase was reached.
Assay for anchorage independence
Colony formation in semisolid agar were assayed by suspending
10
4 cells in 2ml appropriate medium with 0.33% agarose (Gibco)
and placing this suspension on the top of 5ml solidified 0.5%
agarose in the above medium. Triplicate cultures for each cell
clone were maintained at 371C in a 5% CO2 atmosphere. Colonies
over 50mm in diameter were counted after 2 weeks. The
experiments were repeated three times for each clone.
Tumorigenicity assays
Female BALB/C nude mice, 4–6 weeks old, were purchased from
CLEA JAPAN (Tokyo, Japan). The animals received proper care
according to the rules of the Kyoto University Committee on
Animal Care. Animal experiments were performed comply with the
United Kingdom Co-ordinating Committee on Cancer Research
(UKCCCR) Guidelines (Workman et al, 1988). Approximately 10
8
cells per animal were injected subcutaneously in nude mice. If
subcutaneous mass was confirmed, they were killed and the
tumours resected. Cells were considered nontumorigenic if mouse
failed to form tumour within 4 months of injection.
Growth parameters
Population doubling time (PDT) was determined as described
below. Cells (10
4 cellswell
 1) were seeded in each well of a collagen
type-I-coated 24-well plate. Duplicate cell counts were determined
daily for 7 days using a cell counter (Coulter, FL, USA). The
natural logarithm of the mean number of cells per dish was plotted
as a function of time in hours. The maximum doubling time was
calculated from the steepest part of the plot. The experiments were
repeated three times for each clone.
Measurement of bromodeoxyuridine (BrdU) incorporation
rate by flow cytometry
The measurement of BrdU incorporation rate by flow cytometry
was performed using the FITC-conjugated BrdU antibody (Anti-
BrdU) (Becton-Dickinson, Bedford, MA, USA) according to the
manufacturer’s instructions. Briefly, 10
8 cells of each sample were
incubated with 10mM BrdU (Nacalai tesque, Kyoto, Japan) for
30min and washed with PBS. The cells were collected with cell
scraper, fixed in 70% ethanol and denatured with 2 N Hydrochloric
acid/Triton X-100 to produce single-stranded molecules. They
were resuspended in 0.1 M Sodium Tetraborate Decahydrate, pH
8.5 to neutralise the acid. Then, they were incubated with anti-
BrdU (Becton-Dickinson) and were resuspended in a DNA-
staining solution containing propidium iodine and RNase (Cycle
TEST
TM PLUS DNA Reagent Kit) (Becton-Dickinson). The rate of
BrdU incorporation was determined by a FACS Caliber flow
cytometer (Becton-Dickinson) and analysed with CELL Quest
(Becton-Dickinson). The experiments were repeated three times.
Measurement of apoptosis by ELISA using antihistone
antibody
Apoptosis induced by serum deprivation was quantified by
measurement of DNA fragmentation with Cell Death Detection
ELISA (Roche, Mannheim, Germany) as previously described
(Kuroda et al, 2001). Assays were performed in duplicate. Induced
apoptosis was expressed as relative cell death, which was a ratio of
apoptosis level detected in culture without serum to apoptosis level
of control detected in culture with 15% serum. The experiments
were repeated three times.
Measurement of human vascular endothelial growth factor
(VEGF) secretion by ELISA
The level of vascular endothelial growth factor (VEGF) in culture
supernatants was measured by AN’ALYZA
TM (TECHNE, MN,
USA). Each assay was performed in duplicate. The cells were
cultured on 60mm collagen type-I-coated culture dishes. When
confluent, all cultures were then maintained in medium with 15%
FCS at 371C under 20 or 1% O2 concentration for 72h. Cells were
collected with 2.5% trypsin and cell numbers were counted. The
supernatants were collected and the amount of human VEGF in
supernatants was measured with ELISA according to the
manufacturer’s protocol. The values of VEGF were standardised
with cell number. The experiments were repeated three times.
Statistical analysis
For analysis of between-group differences, P-values were deter-
mined using Mann–Whitney’s U-test. A P-value less than 0.05 was
considered significant.
RESULTS
Confirmation of introduced gene expression in OSE cells
To confirm the successful expression of introduced gene products
in OSE cells, the expressions of LT, c-erbB-2 and mutant Ha-ras
protein were confirmed by Western blotting, as shown in Figure
1A, B and C, respectively. The hTERT mRNA expression and
telomerase activity in hTERT-introduced OSE cells were confirmed
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respectively.
Malignant transformation of cultured OSE cells
To evaluate malignant tranformation of OSE cells transfected with
various genes, we analysed immortalization, ability of anchorage-
independent growth and tumorigenicity in mice. Untransfected
OSE cells underwent senescence in 371 passages in culture.
Transfection with LT extended the life span of OSE cells, but, these
LT-transfected OSE cells (OSEþLT) underwent senescence in
972 passages. In contrast, the PDs of OSE cells transfected with a
combination of LT and hTERT (OSEþLTþhTERT) was 116711
passages and the cells did not achieve senescence, suggesting that
they had been immortalized. Ovarian surface epithelium cells
transfected with a combination of LT, hTERT and mutant Ha-ras
(OSEþLTþhTERTþHa-ras), and OSE cells transfected with a
combination of LT, hTERT and c-erbB-2 (OSEþLTþhTERTþc-
erbB-2) clones also were proliferating without senescence with PDs
of 106711 and 106711 passages to date, respectively. As for
growth ability in soft agar, the results of the assay for anchorage-
independent growth are shown in Table 1.
OSEþLT and OSEþLTþhTERT showed slightly enhanced
proliferative activity in soft agar compared with original OSE cells.
The additional introduction of c-erbB-2 or mutant Ha-ras into
OSEþLTþhTERT cells further enhanced the growth activity with
statistical significance (Po0.05). OSEþLTþhTERTþc-erbB-2
cells showed significantly enhanced growth activity in soft agar
compared with that of OSEþLTþhTERTþHa-ras cells
(Po0.05). However, compared with the A2780 ovarian cancer cell
line, colonies of OSEþLTþhTERTþc-erbB-2 cells were small in
number. We examined tumorigenicity in immunodeficient mice.
As shown in Table 2, the OSE cells expressing LT or both LT and
hTERT did not form tumours. In contrast, those cells additionally
transfected with c-erbB-2 and mutant Ha-ras formed tumours in
five of 10 cases (50%), four of 10 cases (40%), respectively, in nude
mice within 1–3 months. On the other hand, injection of A2780 in
nude mice formed tumour in 10 of 10 cases (100%) within 2–3
weeks.
Morphologic features of tumours formed in mice
Morphologic features of inoculated tumours were assessed by
microscopic observation. Histologically, all the tumours expres-
sing mutant Ha-ras were made up in major part of homogenous
spindle-shaped cells with minimal nuclear atypia and infrequent
mitoses (Figure 2A) Immunohistochemically, tumours were
positive for cytokeratin and negative for vimentin, suggesting that
they were epithelial tumours. All the tumours formed by the
injection of c-erbB-2-expressing cells showed the same features as
described above, except that they were positive for vimentin. All
the tumours were confirmed to be derived from the injected OSE
cells by immunohistochemical expression of LT protein
(Figure 2B).
Effect of gene transfections on proliferative activity
To investigate whether introduced genes have an effect on
proliferation activity in OSE cells during the malignant transfor-
mation, PDT measurement and BrdU incorporation assay were
performed. LT-transfected OSE cells showed approximately one
third the PDT of the original OSE cells, indicating that the
proliferative activity accelerated. Moreover, OSEþLTþhTERT
showed a significant decrease in PDT compared with OSEþLT.
Table 1 Anchorage-independent growth of primary OSE, gene-
transfected OSE cells and ovarian cancer cell line
Cell groups The number of colonies
OSE cells 1.270.8
OSE cells+LT 6.071.5
a
OSE cells+LT+hTERT 6.072.1
a
OSE cells+LT+hTERT+Ha-ras 21.873.3
b
OSE cells+LT+hTERT+c-erbB-2 43.475.0
c
A2780 398.4727.7
d
The values are means7s.d. of three clones, OSE cells+LT¼LT-transfected OSE
cells; OSE cells+LT+hTERT¼OSE cells transfected with a combination of LT and
hTERT; OSE cells+LT+hTERT+Ha-ras¼OSE cells transfected with a combination of
LT, hTERT and mutant Ha-ras. OSE cells+LT+hTERT+c-erbB-2¼OSE cells
transfected with a combinationof LT, hTERT and c-erbB-2; A2780¼ovarian cancer
cell line.
aPo0.05 against OSE cells.
bPo0.05 against OSE cells+LT+hTERT.
cPo0.05
against OSE cells+LT+hTERT+Ha-ras.
dPo0.05 against OSE cells+LT+hTERT+c-
erbB-2.
Table 2 Tumour formation incidence of OSE cells and gene-transfected
OSE cells injected into nude mice
Groups BALB/C nude mice
OSE cells 0/10(0%)
OSE cells+LT 0/10(0%)
OSE cells+LT+hTERT 0/10(0%)
OSE cells+LT+hTERT+Ha-ras 4/10(40%)
OSE cells+LT+hTERT+c-erbB-2 5/10(50%)
A2780 10/10(100%)
Cells were subcutaneously injected into nude mice. The results are presented as
number of mice with tumour formation/total number of mice injected with OSE cells
with or without gene transfection, with this value expressed as a percentage in
parentheses. OSE cells+LT¼LT-transfected OSE cells; OSE cells+LT+hTERT¼OSE
cells transfected with a combination of LT and hTERT. OSE cells+LT+hTERT+Ha-
ras¼OSE cells transfected with a combination of LT, hTERT and mutant Ha-ras;O S E
cells+LT+hTERT+c-erbB-2¼OSE cells transfected with a combination of LT, hTERT
and c-erbB-2; A2780¼ovarian cancer cell line.
A
B 1 2 3
1 2 3
21 kDa
94 kDa
C
185 kDa
1 2 3 4 D
1 2 3
145 bp
IS
1 2 34
E
Figure 1 Protein expressions evaluated by Western blotting for LT (A),
mutant Ha-ras (B) and c-erbB-2 (C). The expression of hTERT mRNA and
telomerase activity in OSE cells by RT-PCR, strech PCR, respectively (D,
E). (A) Lane 1: OSE cells; lane 2: LT-transfected OSE cells; lane 3: OSE cells
transfected with a combination of LT and hTERT. (B). Lane 1: OSE cells;
lane 2: OSE cells transfected with a combination of LT and hTERT; lane 3:
OSE cells transfected with a combination of LT, hTERT and mutant Ha-ras.
(C) Lane 1: OSE cells; lane 2: LT-transfected OSE cells; lane 3: OSE cells
transfected with a combination of LT and hTERT; lane 4: OSE cells
transfected with a combination of LT, hTERT and c-erbB-2.( D) Lane 1:
OSE cells; lane 2: LT-transfected OSE cells; lane 3: OSE cells transfected
with a combination of LT and hTERT. (E) Lane 1: positive control; lane 2:
negative control; lane 3: LT-transfected OSE cells; lane 4: OSE cells
transfected with a combination of LT and hTERT. IS¼internal standard.
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with the introduction of c-erbB-2 or mutant Ha-ras into
OSEþLTþhTERT cells (Table 3). By a BrdU incorporation assay,
the populations at the S phase of the total population in
OSEþLTþhTERT were significantly increased compared with
that of NIH 3T3, which has normal cell cycle (45.673.6, 1.671.4%
respectively) (Po0.05). The population rate at S phase in
OSEþLTþhTERTþHa-ras and OSEþLTþhTERTþc-erbB-2
were not significantly different (45.375.3% and 42.676.9%
respectively), consistent with the results of PDT (Table 4).
Effect of the genes on apoptosis resistance
To investigate the detail mechanisms of how c-erbB-2 or mutant
Ha-ras genes are involved in the malignant transformation of OSE
cells, the effect of these genes on apoptosis resistance was
evaluated. Apoptosis was induced by serum deprivation for 72h.
The level of apoptosis in tumorigenic c-erbB-2- or mutant Ha-ras-
expressing OSE cells was measured by ELISA and compared with
that of the nontumorigenic OSE cells. Tumorigenic
OSEþLTþhTERTþc-erbB-2 or mutant Ha-ras demonstrated
the lower level of apoptosis, compared with immortalised
OSEþLTþhTERT cells (Po0.05), demonstrating that the tumori-
genic OSE cells possess enhanced resistance to apoptosis than the
immortalized, but nontumorigenic OSE cells (Figure 3).
Effect of the genes on VEGF secretion
We also analysed whether c-erbB-2 or mutant Ha-ras genes have
effect on upregulation of VEGF secretion. When cells were cultured
under hypoxic condition, VEGF level in supernatant, measured by
ELISA, significantly increased, compared with that under room air
for each immortalized or tumorigenic OSE group. As shown in
Figure 4, in the hypoxic condition, VEGF level for tumorigenic
OSEþLTþhTERTþc-erbB-2 or mutant Ha-ras was significantly
Table 4 Population rate at S phase of cell cycle in gene-transfected OSE
cells
Cell groups Population rate at S phase (%)
NIH 3T3 1.671.4
OSE cells+LT+hTERT 45.673.6
a
OSE cells+LT+hTERT+Ha-ras 45.375.3
OSE cells+LT+hTERT+c-erbB-2 42.676.9
The values are means7s.d. of three clones studied. The results are presented as
population rate at S phase of cell cycle as percentage . NIH 3T3¼fibroblast cell line;
OSE cells+LT+hTERT¼OSE cells transfected with a combination of LT and hTERT;
OSE cells+LT+hTERT+Ha-ras¼OSE cells transfected with a combination of LT,
hTERT and mutant Ha-ras; OSE cells+LT+hTERT+c-erbB-2¼OSE cells transfected
with a combination of LT, hTERT and c-erbB-2.
aPo0.05 against NIH 3T3.
A
B
Figure 2 Microscopic and immunohistochemical findings of tumours
formed in mice. (A) Microscopic findings of tumours expressing mutant
Ha-ras. The tumours, irrespective of the introduced gene, c-erbB-2 or
mutant Ha-ras, were shown to be composed of spindle-shaped cells with
minimal nuclear atypia and less frequent mitoses. (B) Immunohistochem-
istry of tumour cells transfected with a combination of LT, hTERT and
mutant Ha-ras, using the anti-SV40 large T antigen antibody. All tumour
cells were positively stained for the antigen, indicating that these tumours
originate from the injected transformed human OSE cells. Scale bar,
200mm.
Table 3 Population doubling time in primary OSE and gene-transfected
OSE cells
Cell groups Population doubling time(h)
OSE cells 97.4711.7
OSE cells+LT 30.772.3
a
OSE cells+LT+hTERT 7.470.7
b
OSE cells+LT+hTERT+Ha-ras 7.371.3
OSE cells+LT+hTERT+c-erbB-2 7.470.8
The values are means7s.d. of three clones studied. OSE cells+LT¼LT-transfected
OSE cells; OSE cells+LT+hTERT¼OSE cells transfected with a combination of LT
and hTERT; OSE cells+LT+hTERT+Ha-ras¼OSE cells transfected with a combina-
tion of LT, hTERT and mutant Ha-ras; OSE cells+LT+hTERT+c-erbB-2¼OSE cells
transfected with a combination of LT, hTERT and c-erbB-2.
aPo0.05 against OSE
cells.
bPo0.05 against OSE cells+LT.
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Figure 3 Levels of apoptosis induced by serum deprivation in the
immortalised and tumorigenic OSE clones, which expressed as relative cell
death. Relative cell death was a ratio of apoptosis level induced by culture
without serum to apoptosis level of control detected in culture with 15%
serum. The tumorigenic OSE cells expressing c-erbB-2 or mutant Ha-ras
demonstrated the lower level of apoptosis compared with the immorta-
lized OSE cells (Po0.05). Lane 1: OSE cells transfected with a combination
of LT and hTERT, lane 2: OSE cells transfected with a combination of LT,
hTERT and c-erbB-2, lane 3: OSE cells transfected with a combination of LT,
hTERT and mutant Ha-ras.
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(Po0.05).
DISCUSSION
Epithelial ovarian cancer is believed to develop from the OSE
(Scully, 1977), through the amplifications of oncogenes and
mutations of tumour suppressor genes. Although many gene
abnormalities have been detected in ovarian cancers (Matias-Guiu
and Prat, 1998), their roles in the process of ovarian carcinogenesis
have not yet been elucidated. Human OSE cells provide a useful
experimental system for the analysis of ovarian carcinogenesis.
Two studies on immortalization of human OSE cells by the
introduction of LT alone have been already reported (Maines-
Bandiera et al, 1992; Nitta et al, 2001). Maines-Bandiera et al
reported that OSE lines transfected with LT exhibited an extended
life span, but subsequently underwent a progressive reduction of
growth and characteristic morphologic changes associated with
senescence within 20 passages. Nitta et al reported that only six out
of 10 OSE lines transfected with LT were immortalized, and they
had very high telomerase activity. These results suggest that
introduction of LT alone is not sufficient to acquire unlimited
growth capacity, and additional genetic change, that is telomerase
activation, is necessary to accomplish immortalization. It is also
reported that the immortalization of somatic cells by the
introduction of LT alone is very infrequent (Van Der Haegen
and Shay, 1993). On the other hand, a recent report showed that
the transfection of hTERT into LT-transfected human somatic cells
immortalized with the incidence of 100% (Hahn et al, 1999). In the
present study, we tried to immortalize cultured human OSE by the
introduction of hTERT along with LT. As a result, PDs of these
clones had already exceeded 100 without reaching senescence.
Immunohistochemically, the immortalized OSE cells expressing
LT and hTERT were positive for cytokeratin, vimentin, but
negative for CA125, and they were similar to the OSE cells of the
primary culture (data not shown). Therefore, the immortalized
OSE cells seem to maintain phenotypes similar to those of the
original OSE cells, although the immortalized cells showed slight
enhancement of growth ability in soft agar without tumorigenesis
in mice. Thus, immortalized OSE cells expressing LT and hTERT
are considered to be useful for the study of the oncogenic process
of human ovarian cancers.
We selected c-erbB-2 and mutant Ha-ras for the additional gene
transfection for the following reasons. Amplification and/or
overexpression of the c-erbB-2 gene have been reported in 10–
50% of all human epithelial ovarian cancers (Matias-Guiu and
Prat, 1998). The ras oncoprotein consists of three subtypes, that is
Ha-ras, Ki-ras and N-ras, all of which are thought to possess
identical functions. The activation of Ha-ras by point mutation has
been reported to be important for the genesis and maintenance of
solid tumours (Chin et al, 1999). The Ki-ras mutation has been
implicated in the pathogenesis of ovarian cancers (Matias-Guiu
and Prat, 1998).
The additional introduction of c-erbB-2 or mutant Ha-ras in
immortalized OSE cells triggered tumorigenesis in mice. However,
the incidence of tumour formation was 50% and 40% in cases of c-
erbB-2 and mutant Ha-ras introduction, respectively. The low
incidence of tumour formation in our experiments cannot exclude
the possibility that some unknown incidental genetic changes may
be associated, especially because of p53 suppression by LT in the
OSE cells. However, this possibility seems unlikely because all four
tumours expressing mutant Ha-ras formed in the four different
mice had similar histology with the same results of the
immunohistochemical study. The consistency of histological
features among the four different tumours strongly suggests that
the malignant transformation was induced by the transfection of
mutant Ha-ras. Five cases with tumours expressing c-erbB-2 also
showed consistency in the phenotypic features.
The growth activity of immortalized OSE cells expressing either
c-erbB-2 or mutant Ha-ras in soft agar were significantly lower
when compared with that of the ovarian cancer cell line A2780,
which showed tumorigenesis with 100% incidence. The latent
period of tumour formation after injection of the former was 1–3
months, but that of the latter was 2–3 weeks. These results suggest
that the malignant potential of immortalized OSE cells expressing
either c-erbB-2 or mutant Ha-ras may be lower than that of A2780.
The low malignant potential of immortalized OSE cells expressing
either c-erbB-2 or mutant Ha-ras might be one of the causes of the
low incidence of tumour formation in this study. Nonetheless, the
loss of transfected genes after introduction by lipofection, or the
varied efficiency of the post-transcriptional process of introduced
genes may be the cause of the low incidence of tumor formation in
this study. This seems unlikely because the immortalized cells
expressing either c-erbB-2 or mutant Ha-ras showed extension of
their lifespan with stable growth activity, and because none of the
clones showed significant deviation in the results of anchorage-
independent growth and PDT assays. Therefore, we concluded that
the additional introduction of c-erbB-2 or mutant Ha-ras genes in
the immortalized OSE cells was the cause of malignant transfor-
mation of human OSE cells, and these oncogenes might be playing
an important role during the malignant transformation of OSE
cells in vivo.
To clarify the mechanisms underlying introduction of c-erbB-2
or mutant Ha-ras genetic material into the OSE cells and the
resultant malignant transformation, we compared OSE cells before
and after transfection of c-erbB-2 or mutant Ha-ras. Interestingly,
both the doubling times and the population rate at the S phase of
the immortalized cells before the additional gene transfections and
the tumorigenic cells expressing either c-erbB-2 or mutant Ha-ras
were nearly identical. Such a result suggests that the malignant
transformation induced by introduction of c-erbB-2 or mutant Ha-
ras might proceed via signalling pathways unrelated to cell-cycle
regulation. Resistance to apoptosis is considered to be one of the
mechanisms underlying carcinogenesis, and genetic abnormalities
of molecules regulating apoptosis have been detected in ovarian
cancers (Matias-Guiu and Prat, 1998). The tumorigenic OSE cells
expressing either mutant Ha-ras or c-erbB-2 demonstrated the
enhanced resistance to apoptosis induced by serum-deprivation,
compared with the immortalized OSE cells. Neovascularisation is
also critical in tumour formation and VEGF is a major angiogenic
factor. The tumorigenic OSE cells expressing either c-erbB-2 or
mutant Ha-ras demonstrated the increased secretion of VEGF in
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Figure 4 Amount of human VEGF in culture supernatants of the
immortalized and tumorigenic OSE clones. Cells were cultured under
hypoxic condition of 1% O2, and VEGF level for tumorigenic OSE cells
transfected with a combination of LT, hTERT and c-erbB-2 or mutant Ha-
ras was significantly higher than that for immortalized OSE cells (Po0.05).
Lane 1: OSE cells transfected with a combination of LT and hTERT, lane 2:
OSE cells transfected with a combination of LT, hTERT and c-erbB-2, lane 3:
OSE cells transfected with a combination of LT, hTERT and mutant Ha-ras.
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Such a finding suggests that tumorigenic cells might possess a
greater capacity for neovascularisation. Reportedly, ras and
c-erbB-2 genes actually demonstrated angiogenic function, upre-
gulating the expression of VEGF in colon cancer and in head and
neck squamous cell carcinomas, respectively (O-charoenrat et al,
2000; Zhang et al, 2001). Taken together, c-erbB-2 or mutant Ha-
ras might allow malignant transformation of OSE cells via
induction of resistance to apoptosis and enhancement of VEGF
secretion.
In conclusion, immortalization of human OSE cells is induced
efficiently by the transfection of hTERT in addition to LT.
Although the incidence is not so high, introduction of either c-
erbB-2 or mutant Ha-ras into immortalized cells results in
formation of malignant tumours. Further study is necessary to
elucidate the genes involved in the oncogenesis of human ovarian
cancer using this kind of immortalized OSE cells.
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